J&J 3Q Revenues: $17.1 billion (+7%) 3Q Earnings: $3.0 billion (-7%) YTD Revenues: $50.0 billion (+2%) YTD Earnings: $8.3 billion (-12%) Comments: Pharma revenues were up 7% to $6.4 billion, including a 4% drop due to exchange rates. Domestic pharma sales rose 15% while international sales gains of 8% were wiped out by foreign currency rates. Consumer sales fell 4% to $3.6 billion, the result of a 5% currency fluctuation and flat domestic sales. J&J wrote off $679 million in in-proc...